View : 163 Download: 0
Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study
- Title
- Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study
- Authors
- Park; Hyung-Bok; Arsanjani; Reza; Sung; Ji Min; Heo; Ran; Lee; Byoung Kwon; Lin; Fay Y; Hadamitzky; Martin; Kim; Yong-Jin; Conte; Edoardo; Andreini; Daniele; Pontone; Gianluca; Budoff; Matthew J.; Gottlieb; Ilan; Chun; Eun Ju; Cademartiri; Filippo; Maffei; Erica; Marques; Hugo; Gonçalves; Pedro De Araújo; Leipsic; Jonathon A.; Sang-Eun; Shin; Sanghoon; Choi; Jung Hyun; Virmani; Renu; Samady; Habib; Chinnaiyan; Kavitha; Stone; Peter H.; Berman; Daniel S.; Narula; Jagat; Shaw; Leslee J.; Bax; Jeroen J.; Min; James K.; Chang; Hyuk-Jae
- Ewha Authors
- 신상훈; 이상은
- SCOPUS Author ID
- 신상훈; 이상은
- Issue Date
- 2023
- Journal Title
- European Heart Journal Cardiovascular Imaging
- ISSN
- 2047-2404
- Citation
- European Heart Journal Cardiovascular Imaging vol. 24, no. 11, pp. 1536 - 1543
- Keywords
- coronary atherosclerosis; coronary computed tomography angiography; high-risk plaque; mild coronary stenosis; statin
- Publisher
- Oxford University Press
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Aims: To investigate the impact of statins on plaque progression according to high-risk coronary atherosclerotic plaque (HRP) features and to identify predictive factors for rapid plaque progression in mild coronary artery disease (CAD) using serial coronary computed tomography angiography (CCTA). Methods and results: We analyzed mild stenosis (25-49%) CAD, totaling 1432 lesions from 613 patients (mean age, 62.2 years, 63.9% male) and who underwent serial CCTA at a ≥2 year inter-scan interval using the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (NCT02803411) registry. The median inter-scan period was 3.5 ± 1.4 years; plaques were quantitatively assessed for annualized percent atheroma volume (PAV) and compositional plaque volume changes according to HRP features, and the rapid plaque progression was defined by the ≥90th percentile annual PAV. In mild stenotic lesions with ≥2 HRPs, statin therapy showed a 37% reduction in annual PAV (0.97 ± 2.02 vs. 1.55 ± 2.22, P = 0.038) with decreased necrotic core volume and increased dense calcium volume compared to non-statin recipient mild lesions. The key factors for rapid plaque progression were ≥2 HRPs [hazard ratio (HR), 1.89; 95% confidence interval (CI), 1.02-3.49; P = 0.042], current smoking (HR, 1.69; 95% CI 1.09-2.57; P = 0.017), and diabetes (HR, 1.55; 95% CI, 1.07-2.22; P = 0.020). Conclusion: In mild CAD, statin treatment reduced plaque progression, particularly in lesions with a higher number of HRP features, which was also a strong predictor of rapid plaque progression. Therefore, aggressive statin therapy might be needed even in mild CAD with higher HRPs. © 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.
- DOI
- 10.1093/ehjci/jead110
- Appears in Collections:
- 의료원 > 의료원 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML